Novita Pharma Presents Phase 2 NP-G2-044 Data at 2025 ASCO Meeting
23 Apr 2025 //
PR NEWSWIRE
Novita Reports More Positive Ph 2 NP-G2-044 Data At AACR IO Meeting
25 Feb 2025 //
PR NEWSWIRE
23 Apr 2025 //
PR NEWSWIRE
25 Feb 2025 //
PR NEWSWIRE